Arthur He
Stock Analyst at HC Wainwright & Co.
(2.27)
# 2,725
Out of 4,898 analysts
65
Total ratings
47.46%
Success rate
-3.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Maintains: Buy | $6.5 → $120 | $24.41 | +391.60% | 4 | Jun 24, 2025 | |
| SLDB Solid Biosciences | Reiterates: Buy | $20 | $5.47 | +265.63% | 10 | Jun 17, 2025 | |
| VERA Vera Therapeutics | Maintains: Buy | $75 → $85 | $23.78 | +257.44% | 2 | Jun 2, 2025 | |
| PRME Prime Medicine | Downgrades: Neutral | n/a | $4.81 | - | 8 | May 20, 2025 | |
| ADAG Adagene | Reiterates: Buy | $8 | $1.88 | +325.53% | 10 | Apr 3, 2025 | |
| ADAP Adaptimmune Therapeutics | Maintains: Buy | $3.5 → $3 | $0.28 | +967.62% | 6 | Apr 1, 2025 | |
| BCAB BioAtla | Reiterates: Neutral | n/a | $0.40 | - | 8 | Mar 31, 2025 | |
| LVTX LAVA Therapeutics | Reiterates: Neutral | $1.5 | $1.48 | +1.35% | 10 | Mar 31, 2025 | |
| HOOK HOOKIPA Pharma | Downgrades: Neutral | n/a | $1.19 | - | 7 | Jan 10, 2025 |
Nektar Therapeutics
Jun 24, 2025
Maintains: Buy
Price Target: $6.5 → $120
Current: $24.41
Upside: +391.60%
Solid Biosciences
Jun 17, 2025
Reiterates: Buy
Price Target: $20
Current: $5.47
Upside: +265.63%
Vera Therapeutics
Jun 2, 2025
Maintains: Buy
Price Target: $75 → $85
Current: $23.78
Upside: +257.44%
Prime Medicine
May 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.81
Upside: -
Adagene
Apr 3, 2025
Reiterates: Buy
Price Target: $8
Current: $1.88
Upside: +325.53%
Adaptimmune Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $3.5 → $3
Current: $0.28
Upside: +967.62%
BioAtla
Mar 31, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.40
Upside: -
LAVA Therapeutics
Mar 31, 2025
Reiterates: Neutral
Price Target: $1.5
Current: $1.48
Upside: +1.35%
HOOKIPA Pharma
Jan 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.19
Upside: -